In rodents, pharmacological or genetic disruption of RAS action prevents weight-gain, promotes insulin sensitivity and relieves hypertension, implying that the administration of angiotensin converting enzyme inhibitors (ACE-inhibitors) or angiotensin receptor blockers (ARBs) may present an effective treatment for the metabolic syndrome in humans.11 Here, ACE is linked to Hypertension.